| | | | | |
| €36,2275 | -0,53% | €1,64B | €55,67K | |
| €27,1880 | -1,54% | €1,64B | €754,77K | |
RXRX Recursion Pharmaceuticals, Inc. Class A Common Stock | €3,3583 | +12,54% | €1,63B | €24,27M | |
| €27,9982 | -2,32% | €1,63B | €108,66K | |
STEL Stellar Bancorp, Inc. | €32,1382 | +1,06% | €1,63B | €112,53K | |
NUV Nuveen Municipal Value Fund, Inc. | €7,7873 | -0,06% | €1,63B | €142,20K | |
BLDP Ballard Power Systems Inc. | €5,1548 | -1,09% | €1,63B | €4,71M | |
NAC Nuveen California Quality Municipal Income Fund | €10,3759 | +0,12% | €1,62B | €203,61K | |
BWIN The Baldwin Insurance Group, Inc. Class A Common Stock | €16,5275 | +2,39% | €1,62B | €353,96K | |
MESO Mesoblast Limited American Depositary Shares | €12,8484 | +2,89% | €1,62B | €58,08K | |
PRKS United Parks & Resorts Inc. | €34,6580 | +3,15% | €1,62B | €175,24K | |
RAPP Rapport Therapeutics, Inc. Common Stock | €32,3059 | +1,53% | €1,62B | €54,16K | |
SRPT Sarepta Therapeutics,, Inc. Common Stock | €14,3147 | +2,49% | €1,62B | €637,41K | |
ABCL AbCellera Biologics Inc. Common Shares | €5,7199 | +16,28% | €1,62B | €5,81M | |
SONO Sonos, Inc. Common Stock | €13,9105 | +2,89% | €1,61B | €346,03K | |
